Energy transfer mechanisms in pH-tuned aggregates of curcumin.

Curcumin ((1,7-bis-(4-hidroxi-3-metoxifenil)-1,6-heptadieno-3,5-diona)), is a natural yellow-orange polyphenol dye, obtained from Curcuma longa rhizomes, with vast potential in the biotechnology field, such as anti - inflammatory and cancer preventive properties, and a very environmental-sensible structure, mostly resulting in aggregate formations, with low solubility in aqueous solvents and remarkable pH dependence. Hence, it is essential to comprehend its aggregation mechanisms, optical properties and conformational equilibrium to develop curcumin-based drugs and biomaterials for several applications. With the purpose of understand such concepts and its properties, the results presented in this work, obtained through spectroscopic measurements and the Hill's modeling, show a conformational equilibrium, driven by pH, between the enol-enolate and aggregated forms in curcumin, and the respective energy transfer processes between these species. Additionally, the photophysical mechanisms for the energy transfer between aggregated forms, observed with the ellipsometry measurements, showed an "all-or-nothing" character, pointing to a very complex conformation for curcumin aggregates.

Sublingual ketorolac and sublingual piroxicam are equally effective for postoperative pain, trismus, and swelling management in lower third molar removal.

OBJECTIVE: Lower third molar removal provides a clinical model for studying analgesic drugs. The present study's aim was to compare the clinical efficacy of sublingual ketorolac and sublingual piroxicam in managing pain, trismus and swelling after lower third molar extraction in adult volunteers. STUDY DESIGN: In this double-blinded, randomized, crossover investigation, 47 volunteers received for 4 days ketorolac sublingually (10 mg 4 times daily) and piroxicam sublingually (20 mg once daily) during 2 separate appointments after lower third molar extraction of symmetrically positioned lower third molars. A surgeon evaluated objective parameters (surgery duration, mouth opening, rescue analgesic medication, and facial swelling) and volunteers documented subjective parameters (postoperative pain and global evaluation), comparing postoperative results for a total of 7 days after surgery. The means of the objective and subjective parameters were compared for statistical significance (P < .05). RESULTS: Volunteers reported low pain scores during the postoperative period when treated with either sublingual ketorolac or piroxicam. Also, volunteers ingested similar amounts of analgesic rescue medication (paracetamol) when they received either drug sublingually (P > .05). Additionally, values for mouth openings measured just before surgery and immediately after suture removal 7 days later were similar among volunteers (P > .05), and the type of nonsteroidal antiinflammatory drug (NSAID) used in this study showed no significant differences between swellings on the second or seventh days after surgery (P > .05). CONCLUSIONS: Pain, trismus, and swelling after lower third molar extraction, independent of surgical difficulty, were successfully controlled by sublingual ketorolac (10 mg 4 times daily) or sublingual piroxicam (20 mg once daily), and no significant differences were observed between the NSAIDs evaluated.